BondBloxx ETF Trust (CIK 0001879238)

Price not priced yet ⚠ · Not investment advice

BondBloxx ETF Trust (CIK 0001879238)

XSVN SEC NPORT-P
ETF X-ray
Holdings15
Analyzed0 / 15
% Money-losing by weight0.0%

Most doctors who buy XSVN don't know what they own. Here's a snapshot of what the constituents look like through SAVNG's lens.

VERY STALE Holdings as of May 28, 2026 (134 days ago). Over 100 days old — re-fetch from the issuer before using for any decision.

ETF holdings change continuously and our snapshot reflects the most recent disclosure available — typically 1-30 days old for major issuers (iShares, Vanguard, State Street publish daily-to-weekly) or 30-90 days old for funds where we rely on SEC Form NPORT-P (quarterly, with up to 60-day filing lag). Do not use this list to make tax-lot or timing decisions.

Top constituents by weight

TickerNameCUSIPWeightP/IVEPS TTM
— US TREAS NTS 1.5% 11/30/28 91282CDL2 8.94% — —
— US TREAS NTS 2.875% 05/15/32 91282CEP2 8.55% — —
— US TREAS NTS 2.75% 05/31/29 91282CES6 8.52% — —
— US TREAS NTS 2.75% 08/15/32 91282CFF3 7.50% — —
— US TREAS NTS 1.875% 02/15/32 91282CDY4 7.14% — —
— US TREAS NTS 0% 10/31/2028 91282CDF5 6.94% — —
— US TREAS NTS 1.625% 05/15/31 91282CCB5 6.93% — —
— US TREAS NTS 0.625% 08/15/30 91282CAE1 6.80% — —
— US TREAS NTS 1.125% 02/15/31 91282CBL4 6.70% — —
— US TREAS NTS 0.625% 05/15/30 912828ZQ6 6.51% — —
— US TREAS NTS 2.625% 07/31/29 91282CFC0 5.71% — —
— US TREAS NTS 3.125% 08/31/29 91282CFJ5 5.30% — —
— US TREAS NTS 1.375% 11/15/31 91282CDJ7 5.02% — —
— US TREAS NTS 2.375% 03/31/29 91282CEE7 4.69% — —
— US TREAS NTS 3.25% 06/30/29 91282CEV9 3.96% — —

Showing top 25 of 15 by weight. 15 rows lack a ticker — NPORT-P filings only carry CUSIPs, not tickers. Click the CUSIP to look it up on SEC EDGAR. P/IV and EPS shown only for constituents we've analyzed. Sourced from SEC NPORT-P public holdings disclosure.

⚠️ Not investment advice. ETF holdings change continuously. The constituent-level analyses use SAVNG's stock-page methodology and inherit all of its limitations. See the full disclaimer.